Kintara Therapeutics Historical PE Ratio image   This KTRA PE ratio history page last updated 3/30/2023
Kintara Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2023
2/14/2023
6.16-2.10-8.40NA
Q1 2023
11/9/2022
4.55-3.50-14.00NA
Q4 2022
9/27/2022
5.50-3.50-14.00NA
Q3 2022
5/13/2022
9.40-5.50-22.00NA
Q2 2022
2/11/2022
22.50-6.00-24.00NA
Q1 2022
11/15/2021
43.75-12.50-50.00NA
Q4 2021
9/28/2021
43.35-6.50-26.00NA
Q3 2021
5/14/2021
64.00-11.50-46.00NA
Q2 2021
2/12/2021
124.00-11.00-44.00NA
Q1 2021
11/13/2020
76.00-18.00-72.00NA
Q4 2020
9/21/2020
72.5017.5070.001.0
Q3 2020
5/13/2020
32.70-8.50-34.00NA
Q2 2020
2/13/2020
27.50-7.50-30.00NA
Q1 2020
11/14/2019
39.20-10.50-42.00NA
Q4 2019
9/10/2019
31.20-44.50-178.00NA
Q3 2019
5/15/2019
110.50-33.50-134.00NA
Q2 2019
2/12/2019
19.50-40.00-160.00NA
Q1 2019
11/14/2018
30.50-45.00-180.00NA
Q4 2018
9/24/2018
41.00-50.00-200.00NA
Q3 2018
5/17/2018
48.60-65.00-260.00NA
Q2 2018
2/14/2018
68.00-70.00-280.00NA
Q1 2018
11/13/2017
40.35-90.00-360.00NA
Q4 2017
9/28/2017
42.25-100.00-400.00NA
Q3 2017
5/18/2017
121.00-90.00-360.00NA
Kintara Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q2 2023
2/14/2023
6.16-2.10-14.60NA
Q1 2023
11/9/2022
4.55-3.50-18.50NA
Q4 2022
9/27/2022
5.50-3.50-27.50NA
Q3 2022
5/13/2022
9.40-5.50-30.50NA
Q2 2022
2/11/2022
22.50-6.00-36.50NA
Q1 2022
11/15/2021
43.75-12.50-41.50NA
Q4 2021
9/28/2021
43.35-6.50-47.00NA
Q3 2021
5/14/2021
64.00-11.50-23.00NA
Q2 2021
2/12/2021
124.00-11.00-20.00NA
Q1 2021
11/13/2020
76.00-18.00-16.50NA
Q4 2020
9/21/2020
72.5017.50-9.00NA
Q3 2020
5/13/2020
32.70-8.50-71.00NA
Q2 2020
2/13/2020
27.50-7.50-96.00NA
Q1 2020
11/14/2019
39.20-10.50-128.50NA
Q4 2019
9/10/2019
31.20-44.50-163.00NA
Q3 2019
5/15/2019
110.50-33.50-168.50NA
Q2 2019
2/12/2019
19.50-40.00-200.00NA
Q1 2019
11/14/2018
30.50-45.00-230.00NA
Q4 2018
9/24/2018
41.00-50.00-275.00NA
Q3 2018
5/17/2018
48.60-65.00-325.00NA
Q2 2018
2/14/2018
68.00-70.00-350.00NA
Q1 2018
11/13/2017
40.35-90.00NANA
Q4 2017
9/28/2017
42.25-100.00NANA
Q3 2017
5/18/2017
121.00-90.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree KTRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Kintara Therapeutics (KTRA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KTTA PE Ratio History
KURA PE Ratio History
KYMR PE Ratio History
KZR PE Ratio History
LAB PE Ratio History
LABP PE Ratio History
LBPH PE Ratio History
LCI PE Ratio History
LFMD PE Ratio History
LFST PE Ratio History
How should the KTRA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Kintara Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this KTRA Historical PE Ratio page.

What is the average historical PE for KTRA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The KTRA historical PE ratio using the annualized quarterly earnings method works out to 1.0.

What is the average historical PE for KTRA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The KTRA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Kintara Therapeutics Historical PE Ratio information for Kintara Therapeutics' stock. The average KTRA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average KTRA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KTRA historical PE result, against the recent PE: when this page was posted on 3/29/2023, the most recent closing price for KTRA had been 3.64, and the most recent quarterly earnings result, annualized, was 70. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent KTRA PE on 3/29/2023 based on annualized quarterly EPS was 0.1. Based on KTRA's history, that recent PE is low relative to the historical average, with the recent PE 90.0% lower than the historical average PE across our data set for Kintara Therapeutics.

For self directed investors doing their due diligence on KTRA or any other given stock, valuation analysis for KTRA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Kintara Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KTRA. Thanks for visiting, and the next time you need to research KTRA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ETFs Holding HTGC, NXGN Stock Predictions, PG Dividend Growth Rate.

 

Kintara Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.